Description
This product is a stabilized variant of the anti-cd20 antibody rituximab comprising M20I/M81L/A92G/N109D/V263L mutations in the heavy chain. The anti-CD20 antibody variant RWOO6 can be used in some diseases study including human lymphoma, leukemia, and autoimmunity.
Target
MS4A1
Target Alias Name
CD20
Isotype/Mimetic
Human IgG
Animal-Derived Biomaterials Used
None
Sequence Available
No
Original Discovery Method
Human-derived phage display
Original Discovery Information Provided On Datasheet
No
Antibody/Binder Origins
Animal-free discovery, In vitro recombinant expression